(C) 2013 Elsevier Ltd. All
“Coronary artery disease (CAD) has traditionally been thought of as a disease that predominantly affects men. Women, however, are more likely than men to die from a myocardial infarction (MI). In this article, the data on access to cardiovascular care, treatment of stable and unstable coronary disease, and outcomes in women undergoing percutaneous coronary intervention (PCI) will be reviewed. Despite increased awareness of heart disease in women, and improved outcomes after PCI, women with MI have more mortality and delays to treatment than men. Women with CAD have symptoms that differ from men with CAD. Improved understanding of the symptoms of CAD in women by patients and health care providers may improve treatment and outcomes in women SB525334 with CAD. (C) 2010 Elsevier B.V. All rights reserved.”
“The mechanical and the electrical properties of polypyrrole (PPy) fibers HDAC inhibitor and electrochemically deposited PPy films were studied. It was found that the PPy fibers showed
a significantly higher strength than the PPy films due to better orientation of the molecular structure. The electrochemically prepared PPy films had a higher electrical conductivity than that of the fibers at high temperature. At low temperature, the PPy fibers showed the higher conductivity. The conductivity results were analyzed in the frame of the three-dimensional variable range hopping model. The results showed that at room temperature the average hopping distance for the fibers Ro 61-8048 mw was about 4 angstrom while for the films it increases to about 5.7 angstrom. This corresponds to about 1 and 2 monomer units in length for the fiber and film samples, respectively. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3425793]“
“Background: Rodent studies show that oligofructose promotes weight loss, stimulates satiety hormone secretion, reduces energy intake, and improves
Objective: Our objective was to examine the effects of oligofructose supplementation on body weight and satiety hormone concentrations in overweight and obese adults.
Design: This study was a randomized, double-blind, placebo-controlled trial. Forty-eight otherwise healthy adults with a body mass index (in kg/m(2)) > 25 were randomly assigned to receive 21 g oligofructose/d or a placebo (maltodextrin) for 12 wk. Body composition (by dual-energy X-ray absorptiometry); meal tolerance tests, including satiety hormone response; food intake; and subjective appetite ratings were determined.
Results: There was a reduction in body weight of 1.03 +/- 0.43 kg with oligofructose supplementation, whereas the control group experienced an increase in body weight of 0.45 +/- 0.31 kg over 12 wk (P = 0.01). A lower area under the curve (AUC) for ghrelin (P = 0.004) and a higher AUC for peptide YY (PYY) with oligofructose (P = 0.